At AC Immune, we are passionate about making a difference in the lives of people affected by Alzheimer’s and other neurodegenerative diseases. Our goal is to become the global leader in precision medicine of neurodegenerative diseases that are one of the biggest challenges facing society today and future generations.
Latest news
November 18, 2020
November 13, 2020
AC Immune Reports Q3 2020 Financial Results and Provides Business Update
Features
November 4, 2020
The NIH Catalyst: Bringing Precision Medicine to Neuroscience
Company information
Discover more about us, who we are, and how we innovate to improve neurodegenerative disease understanding and develop breakthrough therapies.
Product pipeline
A broad pipeline focused on neurodegenerative diseases with complementary diagnostic agents driven by proprietary technology platforms.
